Home >> Industry News >> FDA approves Ventana CDx to ID patients eligible for Elahere

FDA approves Ventana CDx to ID patients eligible for Elahere

image_pdfCreate PDF

The Ventana FOLR1 RxDx assay is a qualitative immunohistochemical assay using mouse monoclonal anti-FOLR1, clone FOLR1-2.1, intended for use in the assessment of folate receptor alpha protein in formalin-fixed, paraffin-embedded epithelial ovarian, fallopian tube, or primary peritoneal cancer tissue specimens by light microscopy. It is for use with an OptiView DAB IHC detection kit for staining on a BenchMark Ultra instrument.

CAP TODAY
X